Fibromyalgia Support Group
You're not alone in your pain. Fibromyalgia is a condition that can be difficult to diagnose and manage. If you're trying to cope with pain throughout your body, sleep problems, general fatigue, or other common fibromyalgia symptoms, you're in the right place. The community is here for you to talk about therapies and share your challenges.
Safety Alert: Voluntary Recall
October 26, 2010
Actavis Announces a Voluntary Recall of Transdermal Fentanyl 25 mcg
Actavis, a generic drug manufacturer, issued a voluntary recall of 18 lots of their 25 mcg Fentanyl patch on October 21, 2010. One lot was found to be defective, causing the medication to release too quickly into the bloodstream. This lot, along with 17 others, has been recalled. According to Actavis, the Food and Drug Administration (FDA) and wholesale and retail pharmacies have been notified.
For a listing of the affected lots, visit the Actavis website: http://www.actavis.us/en/Fentanyl_Recall.htm
Regretfully, the company has failed to require the public to return their affected lots. As of October 25, the companys website states, Consumers are not being asked to return any product as this issue does not pose a threat of a serious injury or death. Rapid absorption could lead to unintentional side effects such as increased sedation, nausea, vomiting and slowed breathing. The American Pain Foundation strongly urges Actavis to reconsider its first advisory and extend the recall to consumers.
Individuals who have these lots in their possession should:
Contact Actavis and demand a consumer recall and proper replacement. According to the FDA press release, Actavis has operators available to help customers, health professionals and consumers with the following information:
Medical Issue/Adverse Event/Product Questions
1-877-422-7452 (24 hours/day, 7 days/week)
Return/Reimbursement Questions
1-888-896-4562 (24 hours/day, 7 days/week)
Contact the FDA and report your experience. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Online: www.fda.gov/medwatch/report.htm
Contact the pharmacy where this medication was filled and report that you are in possession of an affected lot.
Notify the health care provider who writes your pain medicine prescriptions and ask for guidance.
Notify you insurance provider should a new prescription be written, so that it will be covered.
To Connect and Support our Efforts:
Contribute your voice to the 10,000 Voices campaign.
Please check out our newly launched PainSAFE (Pain Safety & Access For Everyone) website.
Keep up with us on Facebook.
Follow APF on Twitter at www.twitter.com/americanpain for the latest pain news and information and at www.twitter.com/painadvocacy for information on advocacy, policy and public awareness activities.
Get involved by using our online Advocacy Toolkit.
Visit the APF Action Network site to learn what advocates are doing to build the movement for better pain management and get involved!
Visit the Exit Wounds site to learn more about our Military and Veterans living with pain.
Join PainAid, our online support community.
Support our efforts by donating to the cause. Donate Now.
October 26, 2010
Actavis Announces a Voluntary Recall of Transdermal Fentanyl 25 mcg
Actavis, a generic drug manufacturer, issued a voluntary recall of 18 lots of their 25 mcg Fentanyl patch on October 21, 2010. One lot was found to be defective, causing the medication to release too quickly into the bloodstream. This lot, along with 17 others, has been recalled. According to Actavis, the Food and Drug Administration (FDA) and wholesale and retail pharmacies have been notified.
For a listing of the affected lots, visit the Actavis website: http://www.actavis.us/en/Fentanyl_Recall.htm
Regretfully, the company has failed to require the public to return their affected lots. As of October 25, the companys website states, Consumers are not being asked to return any product as this issue does not pose a threat of a serious injury or death. Rapid absorption could lead to unintentional side effects such as increased sedation, nausea, vomiting and slowed breathing. The American Pain Foundation strongly urges Actavis to reconsider its first advisory and extend the recall to consumers.
Individuals who have these lots in their possession should:
Contact Actavis and demand a consumer recall and proper replacement. According to the FDA press release, Actavis has operators available to help customers, health professionals and consumers with the following information:
Medical Issue/Adverse Event/Product Questions
1-877-422-7452 (24 hours/day, 7 days/week)
Return/Reimbursement Questions
1-888-896-4562 (24 hours/day, 7 days/week)
Contact the FDA and report your experience. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Online: www.fda.gov/medwatch/report.htm
Contact the pharmacy where this medication was filled and report that you are in possession of an affected lot.
Notify the health care provider who writes your pain medicine prescriptions and ask for guidance.
Notify you insurance provider should a new prescription be written, so that it will be covered.
To Connect and Support our Efforts:
Contribute your voice to the 10,000 Voices campaign.
Please check out our newly launched PainSAFE (Pain Safety & Access For Everyone) website.
Keep up with us on Facebook.
Follow APF on Twitter at www.twitter.com/americanpain for the latest pain news and information and at www.twitter.com/painadvocacy for information on advocacy, policy and public awareness activities.
Get involved by using our online Advocacy Toolkit.
Visit the APF Action Network site to learn what advocates are doing to build the movement for better pain management and get involved!
Visit the Exit Wounds site to learn more about our Military and Veterans living with pain.
Join PainAid, our online support community.
Support our efforts by donating to the cause. Donate Now.
deleted_user
Thanks for the heads up. Didn't this happen a few years ago also?
Join the Conversation
-
My 6mo twin DD's are EBF and just started rice cereal on the first. Everything has been going fine except this morning one of them had a diaper rash (lots of redness around her anus). I read this as one of the signs of an allergy. BUT I did just buy a different brand diaper yesterday (which they have used randomly before w/no issues). Do you think its the cereal or the diaper? Im ready to start...